SCHEMBL20219444

SCHEMBL20219444

C=Cc1ncc(OCCCc2ccncc2)c(NCCCC)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 6/20 0.42
▸ TLR8 Q9NR97 5/20 0.42
▸ CNR2 P34972 2/20 0.38
▸ LATS1 O95835 2/20 0.38
▸ LATS2 Q9NRM7 2/20 0.38
▸ PGK1 P00558 1/20 0.38
▸ STK17A Q9UEE5 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ STK17B O94768 1/20 0.35
▸ FLT3 P36888 1/20 0.34
▸ TYRO3 Q06418 1/20 0.34
▸ MERTK Q12866 1/20 0.34
▸ GAS6 Q14393 1/20 0.34
▸ KDM6B O15054 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472434 0.88 CYP2D6 (0.40) TLR7TLR8LATS1LATS2CYP1A2
SCHEMBL23472518 0.84 TLR7 (0.45) TLR7TLR8CNR2LATS1LATS2
SCHEMBL23472423 0.83 MEN1 (0.45) LMNAHTTSMN1; SMN2TSHR
SCHEMBL15470120 0.83 TLR7 (0.55) TLR7TLR8CYP1A2CYP3A4
SCHEMBL23472511 0.81 CHRNB2 (0.43) TLR7TLR8CYP1A2CYP3A4HTT
SCHEMBL20219267 0.79 TLR7 (0.44) TLR7TLR8CNR2LATS1LATS2
SCHEMBL23472437 0.79 KMT2A (0.37) TLR7TLR8STK17ACYP1A2CYP3A4
SCHEMBL20219406 0.78 S1PR4 (0.35) TLR7TLR8STK17ALMNAHTT
SCHEMBL23472425 0.77 CASP6 (0.41) TLR7TLR8CYP1A2CYP3A4LMNA
SCHEMBL23472593 0.77 CYP1A2 (0.43) TLR7TLR8STK17ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback